Nontransferrin-bound iron in transfused patients with sickle cell disease

International Journal of Laboratory Hematology

Volumn 33, Issue 2, 2011, Pages 133-137

  Inati, A ^a,b,c   Musallam, K M ^d   Cappellini, M D ^e   Duca, L ^e   Taher, A T ^d  

^a RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^b Nini Hospital   (Lebanon)

^c UNIVERSITY OF BALAMAND   (Lebanon)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Iron overload; Nontransferrin bound iron; Serum marker; Sickle cell disease; Transfusion

Indexed keywords

IRON; TRANSFERRIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IRON OVERLOAD; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; LIVER; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79952470934     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01224.x     Document Type: Article

References (21)

1. Anderson L.J., Holden S., Davis B., Prescott E., Charrier C.C., Bunce N.H., Firmin D.N., Wonke B., Porter J., Walker J.M. & Pennell D.J. (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal 22, 2171-2179.
2. Aruoma O.I., Bomford A., Polson R.J. & Halliwell B. (1998) Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 72, 1416-1419.
3. Breuer W., Hershko C. & Cabantchik Z.I. (2000) The importance of non-transferrin bound iron in disorders of iron metabolism. Transfusion Science 23, 185-192.
4. Cappellini M.D., Tavazzi D., Duca L., Marelli S. & Fiorelli G. (2002) Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in β-thalassemia intermedia. Transfusion Science 23, 245-246.
5. Cighetti G., Duca L., Bortone L., Sala S., Nava I., Fiorelli G. & Cappellini M.D. (2002) Oxidative status and malondialdehyde in β-thalassaemia patients. European Journal of Clinical Investigation 32, 55-60.
6. Finch C.A., Lee M.Y. & Leonard J.M. (1982) Continuous RBC transfusions in patients with sickle cell disease. Archives of Internal Medicine 142, 279-282.
7. Fung E.B., Harmatz P.R., Lee P.D., Milet M., Bellevue R., Jeng M.R., Kalinyak K.A., Hudes M., Bhatia S., Vichinsky E.P. & Multi-Centre Study of Iron Overload Research Group (2006) Increased prevalence of iron-overload associated endocriniopathy in thalassaemia versus sickle-cell disease. British Journal of Haematology 135, 574-582.
8. Gosriwatana I., Loreal O., Lu S., Brissot P., Porter J. & Hider R.C. (1999) Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Annals of Biochemistry 273, 212-220.
9. Ludwiczek S., Aigner E., Theurl I. & Weiss G. (2003) Cytokinemediated regulation of iron transport in human monocytic cells. Blood 101, 4148-4154.
10. Pakbaz Z., Fischer R., Fung E., Nielsen P., Harmatz P. & Vichinsky E. (2007) Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatric Blood and Cancer 49, 329-332.
11. Piga A., Longo F., Duca L., Roggero S., Vinciguerra T., Calabrese R., Hershko C. & Cappellini M.D. (2009) High nontransferrin bound iron levels and heart disease in thalassemia major. American Journal of Hematology 84, 29-33.
12. Pippard M.J. (1994) Secondary iron overload. In: Iron Metabolism in Health and Disease (eds J.H. Brock, J.W. Halliday & M.J. Pippard), pp. 272-300. W.B. Saunders Ltd, London.
13. Porter J.B., Abeysinghe R.D., Marshall L., Hider R.C. & Singh S. (1996) Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88, 705-713.
14. al-Refaie F.N., Wickens D.G., Wonke B., Kontoghiorghes G.J. & Hoffbrand A.V. (1992) Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. British Journal of Haematology 82, 431-436.
15. St Pierre T.G., Clark P.R., Chua-Anusorn W., Fleming A.J., Jeffrey G.P., Olynyk J.K., Pootrakul P., Robins E. & Lindeman R. (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 15, 855-861.
16. Taher A., Musallam K.M., El Rassi F., Duca L., Inati A., Koussa S. & Cappellini M.D. (2009) Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. British Journal of Haematology 146, 569-572.
17. Tavazzi D., Duca L., Graziadei G., Comino A., Fiorelli G. & Cappellini M.D. (2001) Membrane-bound iron contributes to oxidative damage of β-thalassaemia intermedia erythrocytes. British Journal of Haematology 112, 48-50.
18. Vichinsky E., Butensky E., Fung E., Hudes M., Theil E., Ferrell L., Williams R., Louie L., Lee P.D. & Harmatz P. (2005) Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. American Journal of Hematology 80, 70-74.
19. Voskaridou E., Douskou M., Terpos E., Papassotiriou I., Stamoulakatou A., Ourailidis A., Loutradi A. & Loukopoulos D. (2004) Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. British Journal of Haematology 126, 736-742.
20. Walter P.B., Fung E.B., Killilea D.W., Jiang Q., Hudes M., Madden J., Porter J., Evans P., Vichinsky E. & Harmatz P. (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. British Journal of Haematology 135, 254-263.
21. Wood J.C., Tyszka J.M., Carson S., Nelson M.D. & Coates T.D. (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103, 1934-1936.